» Articles » PMID: 18841331

Genetic Engineering of T Cells for Adoptive Immunotherapy

Overview
Journal Immunol Res
Date 2008 Oct 9
PMID 18841331
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

To be effective for the treatment of cancer and infectious diseases, T cell adoptive immunotherapy requires large numbers of cells with abundant proliferative reserves and intact effector functions. We are achieving these goals using a gene therapy strategy wherein the desired characteristics are introduced into a starting cell population, primarily by high efficiency lentiviral vector-mediated transduction. Modified cells are then expanded using ex vivo expansion protocols designed to minimally alter the desired cellular phenotype. In this article, we focus on strategies to (1) dissect the signals controlling T cell proliferation; (2) render CD4 T cells resistant to HIV-1 infection; and (3) redirect CD8 T cell antigen specificity.

Citing Articles

High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits.

Kohlgruber A, Dezfulian M, Sie B, Wang C, Kula T, Laserson U Nat Biotechnol. 2024; .

PMID: 38956325 DOI: 10.1038/s41587-024-02248-6.


Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape.

Miliotou A, Georgiou-Siafis S, Ntenti C, Pappas I, Papadopoulou L Curr Issues Mol Biol. 2023; 45(11):9181-9214.

PMID: 37998753 PMC: 10670245. DOI: 10.3390/cimb45110576.


Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology.

Yoo H, Harapan B Immunol Res. 2021; 69(6):471-486.

PMID: 34554405 PMC: 8580929. DOI: 10.1007/s12026-021-09236-x.


A narrative review of chimeric antigen receptor-T (CAR-T) cell therapy for lung cancer.

Liu Y, He Y Ann Transl Med. 2021; 9(9):808.

PMID: 34268421 PMC: 8246176. DOI: 10.21037/atm-20-5419.


Surface Functionalization with Polyethylene Glycol and Polyethyleneimine Improves the Performance of Graphene-Based Materials for Safe and Efficient Intracellular Delivery by Laser-Induced Photoporation.

Liu J, Li C, Brans T, Harizaj A, Van de Steene S, Beer T Int J Mol Sci. 2020; 21(4).

PMID: 32102402 PMC: 7073198. DOI: 10.3390/ijms21041540.


References
1.
Hassan R, Bera T, Pastan I . Mesothelin: a new target for immunotherapy. Clin Cancer Res. 2004; 10(12 Pt 1):3937-42. DOI: 10.1158/1078-0432.CCR-03-0801. View

2.
Cooper L, Al-Kadhimi Z, DiGiusto D, Kalos M, Colcher D, Raubitschek A . Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies. Blood Cells Mol Dis. 2004; 33(1):83-9. DOI: 10.1016/j.bcmd.2004.03.003. View

3.
Chemnitz J, Parry R, Nichols K, June C, Riley J . SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol. 2004; 173(2):945-54. DOI: 10.4049/jimmunol.173.2.945. View

4.
Mitchell R, Beitzel B, Schroder A, Shinn P, Chen H, Berry C . Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004; 2(8):E234. PMC: 509299. DOI: 10.1371/journal.pbio.0020234. View

5.
Nadler L, Anderson K, Marti G, Bates M, Park E, Daley J . B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983; 131(1):244-50. View